🟢 Femasys is trading 6.6% up today after UNC Health partnership expands fertility care access

Femasys is trading 6.63% up now at $2.98 after continued investor reaction to its UNC Health partnership.

• The agreement brings FemVue, SpermVue, and FemaSeed Complete into UNC Health OB/GYN practices statewide, expanding access to fertility diagnostics and first-line treatment.
• Announced August 26, 2026, recent coverage linked the partnership to Femasys shares moving higher; broader markets were only modestly positive, suggesting the company-specific catalyst is the primary driver.